Court Favors Cardium In Gene Therapy Patent Dispute
The U.S. Court of Appeals for the Federal Circuit has ruled that Arch Development Corp. and Arch's licensee, Boston Scientific Corp. will not be able to assert patents relating to a...To view the full article, register now.
Already a subscriber? Click here to view full article